Table 3.
Number of Admissions for ACSCs During the Early COVID-19 Pandemic (March–August 2020) Stratified by Racea
| Variable | African American n (%) | Asian n (%) | Latinx n (%) | Whiteb n (%) | Total n (%) |
|---|---|---|---|---|---|
| CHF | 47 (−15) | 12 (−14) | 26 (−41) | 70 (−55) | 155 (−42) |
| COPD/asthma | 4 (−77) | 6 (+20) | 5 (−44) | 13 (−71) | 28 (−63) |
| Diabetes | 25 (+127%) | 2 (0) | 17 (+6) | 33 (−58) | 77 (+20) |
| Hypertension | 5 (−17) | 0 (−100) | 2 (−75) | 8 (−11) | 15 (−40) |
| Pneumonia | 8 (+700) | 1 (−67) | 4 (−50) | 18 (−58) | 31 (−44) |
| UTI | 3 (−70) | 5 (0) | 11 (0) | 22 (−49) | 41 (−41) |
| Total | 92 (−8) | 26 (−16) | 65 (−32) | 164 (−50) | 347 (−38) |
a
Numbers in parentheses represent the absolute percent change from pre-pandemic times for that specific ACSC and race/ethnicity.
b
Non-Hispanic White.
ACSC, ambulatory care-sensitive condition; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; UTI, urinary tract infection.